Your browser doesn't support javascript.
loading
Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer.
Kim, Mark Seungwook; Ma, Shaolin; Chelariu-Raicu, Anca; Leuschner, Carola; Alila, Hector W; Lee, Sanghoon; Coleman, Robert L; Sood, Anil K.
Afiliación
  • Kim MS; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. mkim3@mdanderson.org asood@mdanderson.org.
  • Ma S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chelariu-Raicu A; Reproductive Medicine Research Center, the Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Leuschner C; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alila HW; Department of Obstetrics and Gynecology, University of Hospital, LMU Munich, Germany.
  • Lee S; Esperance Pharmaceuticals, Inc., Houston, Texas.
  • Coleman RL; Esperance Pharmaceuticals, Inc., Houston, Texas.
  • Sood AK; Department of System Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mol Cancer Ther ; 19(11): 2396-2406, 2020 11.
Article en En | MEDLINE | ID: mdl-32943548
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Proteínas Recombinantes de Fusión / Receptores LHRH / Terapia Molecular Dirigida / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Proteínas Recombinantes de Fusión / Receptores LHRH / Terapia Molecular Dirigida / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2020 Tipo del documento: Article